Home
Companies
Engage Bio

mRNA Immunotherapies to Eliminate Cancer

Engage Bio is developing mRNA immunotherapies to defeat cancer. Our founders have deep experience in immunotherapy development, including four drugs in the clinic, and in building mRNA therapeutics platforms. Our approach is to provide cancer cells with instructions to make and gradually release our drugs within solid tumors. This local therapy allows us to eliminate tumors while sparing healthy distant tissues.

Engage Bio
Founded:2021
Team Size:5
Location:Santa Clara, CA

Active Founders

Will Olsen

Co-Founder & CEO of Engage Bio

Will Olsen
Will Olsen
Engage Bio

Kathryn Kwant

Kathryn has 12 years of experience engineering proteins for improved properties. She spent 5 years as a key early scientist at Harpoon Therapeutics, where she developed bispecific immunotherapies and protease activated immunotherapies. She has helped develop multiple drugs that are currently in the clinic to treat various cancers and has multiple patents and patent applications.

Kathryn Kwant
Kathryn Kwant
Engage Bio